Schedule III drugs are substances classified under the U.S. Controlled Substances Act (CSA) with a recognized medical use and a moderate to low potential for physical and psychological dependence compared to Schedule I and II substances.
This category includes medications and compounds that are medically valuable but still subject to controlled distribution and oversight. Examples historically include products with low-dose codeine (like certain Tylenol with codeine formulas), ketamine, anabolic steroids, and testosterone.
At JRL CHARTS, this tag serves as a central hub for coverage on Schedule III drug policy, including federal scheduling changes like the recent reclassification moves affecting cannabis, DEA scheduling updates, implications for clinical research, and how classification shifts impact patients, medical providers, and healthcare policy.
Explore the latest federal actions, legal interpretations, scientific studies, and regulatory developments shaping Schedule III drug classifications and the broader U.S. drug policy landscape.
Related Coverage Links on JRL CHARTS:
• Get the Latest in LGBT Politics USA Exclusively on JRL CHARTS
• Where LGBTQ Texans Can Find Safety, Support, and Advocacy Resources
• Texas Passes THC Hemp Ban Amid Medical Marijuana Expansion
• Sexy Pot Marijuana-Shaped Massager is a Must Stock
Media Partners: For licensing inquiries, media usage rights, or republication requests, please visit our Contact Us page. All content © JRL CHARTS Media Network. Unauthorized use is strictly prohibited.
